Baricitinib
Active substance: baricitinib
TABLET, FILM COATED · BARICITINIB 4 mg/1
United StatesActive
Marketing holder: Eli Lilly and Company
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- BARICITINIB · 4 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
| EU 1 |
|
Import and control
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-66c6-797e-81df-865f7869e6d3,01a120c3-81d3-7642-8d4f-8f5f2cc4c10a,01a120c3-84e3-7645-9be3-60139b2ecbc5,01a120c3-c2fa-7aa2-af71-4cf61d0befde,01a120c5-cce8-7441-8a35-29196e77bb9c;count=5 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-9239-7195-9fdc-407ad98ce3d4,01a1208c-cdce-75ab-84ce-7364b858ee48,01a12094-540a-7aab-91ec-90fba0aee6c0,01a1209e-267a-7abe-882b-dc79db233264;count=4 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0002-6885
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0002-6885 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0002-6885 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0002-6885 · Verified 2026-10-09 · open in source